Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus are reusable insulin pens equipped with NFC (Near Field Communication) technology – meaning that they must be scanned in close proximity to move the data off the pen and to another device. NovoPen 6 and NovoPen Echo Plus can allow healthcare professionals to view their patients’ insulin dosing information, helping to facilitate more productive consultations and support personalised treatment guidance.

NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk

A Swedish study conducted by Novo Nordisk from 2017-2018 showed that, in a real-world setting, using the NovoPen ® 6 smart insulin pen to administer insulin can give people with type 1 diabetes up to two extra hours of glycaemic control per day. The kid-friendly Echo Plus allows for half-unit dosing and a maximum 30-unit injection, whereas the NovoPen 6 has a minimum dose of one unit and a maximum dose of 60 units. He admits that prior to FreeStyle LibreLink connectivity being made available with the pens, using Glooko to link up the smart pen alongside LibreLink for sensor readings was useful, but also a challenge.Novo Nordisk has announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, are now available on prescription for people living with diabetes treated with Novo Nordisk insulin in the UK. Novo Nordisk’s smart connected pens are an example of how technology can support people living with diabetes to gain greater insight into the management of their diabetes, on their journey to becoming experts in their diabetes. The NICE British National Formulary (BNF) site is only available to users in the UK (England, Scotland, Wales and Northern Ireland).

NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To

Novo Nordisk long-term strategy involves enhanced access to the connected pens and offering personalised treatment guidance solutions for people living with diabetes. We spoke to two members of the diabetes community to understand their experiences with smart insulin pens and explore the impact that widespread use of these pens could have on diabetes teams as well as people with diabetes. Commenting on the interoperability between the smart pens and FreeStyle LibreLink, James says: “I have found registering NovoPen devices onto the LibreLink app very simple for myself and people in my clinic.Pinder Sahota, general manager, Novo Nordisk UK, said: “We believe digital innovation of devices and treatments has the potential to transform people’s lives and help alleviate the daily burden of living with diabetes.

NovoPen® 6 | Hypodermic insulin injection pens | Medical NovoPen® 6 | Hypodermic insulin injection pens | Medical

Novo Nordisk will launch the NovoPen 6 and NovoPen Echo Plus in early 2019 in select countries, with an eventual launch in over 50 countries. Results from an observational study indicate that using NovoPen® 6 to administer their insulin could give people living with type 1 diabetes close to two extra hours of improved glucose levels (measured as HbA1c 3. Reusable Novo Nordisk smart insulin pens will launch first, followed by a Bluetooth attachment for disposable pens later in 2019.

We’ve seen big strides in the development of insulin pump technology in recent years, and now evolving smart insulin pen technology is showing how these devices can make life a little easier for people who use multiple daily injections. This data can be uploaded to a compatible app and viewed by people living with diabetes and their healthcare professionals.

Smart insulin pens: How they work, and your experiences of

NovoPen ® 6 / NovoPen Echo ® Plus comes with a three-year full guarantee and Novo Nordisk will replace any pens that are faulty within that period. Dr Tomas Griffin, a Senior Lecturer in Medicine at the University of Limerick, who spoke about smart pens and insulin pumps at the Type 1 Tech Conference 2022, says: “Smart connected insulin devices (such as smart connected pens, caps and attachments) represent the new generation of technologies designed to help people on multiple daily injections manage their diabetes.Novo Nordisk has signed collaboration agreements with Glooko, Roche and DexCom to support the future integration of its NovoPen 6 and NovoPen Echo Plus insulin pens with digital health solutions.